Cdk5 mediates rotational force-induced brain injury.

Area of Science:

• Neuroscience
• Trauma Research
• Biochemistry

Background:

• Traumatic brain injuries (TBIs) are common, often caused by impacts involving rotational forces.
• While linear head trauma is modeled, rotational TBI (rTBI) mechanisms and consequences remain less understood.
• rTBI can lead to immediate and long-term neurological damage, including neuroinflammation and cell death.

Purpose of the Study:

• To develop and characterize a novel rodent model of repetitive rotational head trauma.
• To investigate the molecular mechanisms underlying rTBI-induced neuropathology.
• To evaluate the therapeutic potential of inhibiting key molecular pathways in rTBI.

Main Methods:

• Developed a new rodent model for repetitive rotational head trauma (rTBI).
• Assessed acute and chronic pathological, behavioral, and electrophysiological outcomes post-rTBI.
• Employed Cdk5-enriched phosphoproteomics to identify downstream targets.
• Investigated the effects of pharmacological Cdk5 inhibition.

Main Results:

• The new rTBI model demonstrated significant acute and prolonged pathological, behavioral, and electrophysiological deficits.
• Aberrant Cyclin-dependent kinase 5 (Cdk5) activity was identified as a key mediator of rTBI.
• Pharmacological inhibition of Cdk5 significantly ameliorated cognitive impairments and neuropathology following rTBI.

Conclusions:

• Repetitive rotational head trauma induces complex and lasting brain damage.
• Cdk5 plays a critical role in mediating the detrimental effects of rTBI.
• Targeting Cdk5 represents a promising therapeutic strategy for mitigating the consequences of rotational TBI.